Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024)
Neuroone Medical Technologies posted quarterly Amortization of Deferred Charges of $192647.0 for Q4 2024, up 1988.09% on a QoQ basis from $9226.0 in Q3 2018.
Neuroone Medical Technologies (NMTC) has 4 years of Amortization of Deferred Charges data on file, last reported at $192647.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Deferred Charges changed N/A year-over-year to $192647.0; the trailing twelve-month figure through Sep 2025 stood at $192647.0 (changed N/A YoY), and the FY2025 full-year result was $192647.0, up 90.12% from the prior year.
- Amortization of Deferred Charges for Q4 2024 stood at $192647.0, up from $9226.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $192647.0 in Q4 2024 and bottomed at $192647.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 192,647.00 |
| Dec 31, 2024 | 192,647.00 |
| Sep 30, 2018 | 9,226.00 |
| Sep 30, 2018 | 9,226.00 |
| Jun 30, 2018 | 141,510.00 |
| Jun 30, 2018 | 141,510.00 |
| Mar 31, 2018 | 70,505.00 |
| Mar 31, 2018 | 70,505.00 |
| Sep 30, 2017 | 284,637.00 |
| Sep 30, 2017 | 284,637.00 |
| Dec 31, 2016 | 4,356.00 |
| Dec 31, 2016 | 4,356.00 |